T-cell Prolymphocytic Leukemia: Clinical Trials

1 trial for T-cell Prolymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow T-cell Prolymphocytic Leukemia: new trials by email Literature Review of T-cell Prolymphocytic Leukemia trials Research Report on T-cell Prolymphocytic Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
anti-CD7 CAR-pNK cells - Acute Myeloid Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Phase 1 / Phase 2UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102016-03-012016-12-06

Narrower conditions

Enteropathy-Associated T-Cell Lymphoma (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Prolymphocytic, T-Cell (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, T-Cell (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Prolymphocytic (1)  ·  Leukemia, T-Cell (1)  ·  Lymphadenopathy (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)

Interventions

Sensitivity and Specificity (1)

Sponsors

PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1)

Countries

China (1)

Top investigators

Lin Yang, Ph.D. (1)

Results publications

PMID 28054442